<DOC>
	<DOCNO>NCT00795262</DOCNO>
	<brief_summary>We evaluate combination quinapril alpha lipoic acid patient diabetes mellitus hypertension . We determine whether combination quinapril lipoic acid compare quinapril placebo provide benefit systemic blood pressure proteinuria .</brief_summary>
	<brief_title>Effects Quinapril 40 mg With Alpha Lipoic Acid Placebo Diabetes Hypertension</brief_title>
	<detailed_description>The participant randomize either quinapril 40 mg alpha lipoic acid versus quinapril 40 mg placebo 8 week . There wash period 4 week cross . The participant assign cross 8 week opposite therapy .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<mesh_term>Quinapril</mesh_term>
	<criteria>Patients diagnosis diabetes mellitus define fast blood glucose level great ot equal 126mg/dL systolic BP great 125 mm Hg time screen include study . Patients may antihypertensive medication ACE inhibitor ARB therapy time enrollment . Systolic blood pressure &gt; 180 mmHg Creatinine &gt; 2.5 mg/dl Glycosylated hemoglobin &gt; 7.5 % Congestive heart failure ( NYHA Class II , III IV ) Coronary angiography plan prior baseline sample Chronic autoimmune disease Chronic inflammatory disease know cancer evolution life expectancy &lt; 1 year Immunosuppressives treatment investigational drug within last 30 day Pregnant nursing woman Participants experience side effect quinapril and/or alpha lipoic acid Women childbearing potential Women childbearing potential enrol study use one acceptable method birth control list 1 . Abstinence , mean total lack sexual activity . 2 . Oral contraceptive ( `` pill '' ) , 3 . Contraceptive injection , 4 . Intrauterine device , 5 . Doublebarrier method ( diaphragm condom + spermicidal cream ) , 6 . Contraceptive patch , 7 . Male partner sterilization . Pregnancy Any pregnancy occur study participation must report Principal Investigator study coordinator early . The pregnancy must follow determine outcome status mother child . To ensure subject safety , subject becomes pregnant study discontinue trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>brachial artery reactivity</keyword>
</DOC>